Skip the primary navigation if you do not want to read it as the next section.
Skip the main content if you do not want to read it as the next section.
'Count epilepsy out' campaign
"Count epilepsy out. Swapping epilepsy drugs could have an enormous cost to our lives – the government says it understands, but now they must make sure it can never happen."
The Department of Health consultation on generic substitution ended on 30 March 2010. Thank you to everybody who joined the campaign. We now await the Department of Health's decision.
More information
Consultation paper and background documents (opens in a new window)
The Department of Health's (DoH) consultation paper and background documents are available on the DoH website.
Consultation - key points
Key points from the Department of Health's consultation on proposals to implement generic substitution in primary care in England.
NSE's report to the Department of Health
Our report to the Department of Health about the risks of substitution of anti-epileptic drugs has been acknowledged in the consultation document.
Background to the consultation
Explains all the implications of switching from branded to generic drugs.
Generic and branded drugs factfile
The differences between generic and branded anti-epileptic medication and ways that you can help your treatment to stay effective.
